Vitamin d status and parathyroid hormone levels in patients with obstructive sleep apnea

Respiration

Volumn 86, Issue 4, 2013, Pages 295-301

  Barceló, Antonia ^a,h   Esquinas, Cristina ^d   Piérola, Javier ^c,h   De La Peña, Mónica ^b,h   Sánchez De La Torre, Manuel ^d,h   Montserrat, Josep María ^e,h   Marín, José María ^f,h   Duran, Joaquín ^g,h   Arqué, Meritxell ^c,h   Bauça, Josep Miquel ^a   Barbé, Ferrán ^d,h  

^a Servei d'Anàlisis Clíniques   (Spain)

^b Pneumologia ^*  (Spain)

^c HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

^f HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^g HOSPITAL TXAGORRITXU   (Spain)

^h INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Metabolic syndrome; Parathyroid hormone; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; TRIACYLGLYCEROL; URIC ACID; CHOLESTEROL; VITAMIN D;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DIABETES MELLITUS; EDUCATION PROGRAM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; SEASONAL VARIATION; SLEEP DISORDERED BREATHING; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; VITAMIN BLOOD LEVEL; APNEA HYPOPNEA INDEX; HORMONE BLOOD LEVEL; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; WAIST CIRCUMFERENCE;

ADULT; AGED; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PARATHYROID HORMONE; PREVALENCE; SLEEP APNEA, OBSTRUCTIVE; SPAIN; VITAMIN D;

EID: 84888035976     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000342748     Document Type: Article

References (38)

1. Douglas NJ, Polo O: Pathogenesis of sleep apnoea/hypopnoea syndrome. Lancet 1994; 344: 653-655.
2. Young T, Peppard PE, Gottlieb DJ: Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165: 1217-1239.
3. Levy P, Bonsignore MR, Eckel J: Sleep, sleepdisordered breathing and metabolic consequences. Eur Respir J 2009; 34: 243-260.
4. McArdle N, Hillman D, Beilin L, Watts G: Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 2007; 175: 190-195.
5. Lavie L, Polotsky V: Cardiovascular aspects in obstructive sleep apnea syndrome-molecular issues, hypoxia and cytokine profiles. Respiration 2009; 78: 361-370.
6. Holick MF: Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
7. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF: Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52: 1949-1956.
8. Reddy VS, Good M, Howard PA, Vacek JL: Role of vitamin D in cardiovascular health. Am J Cardiol 2010; 106: 798-805.
9. Adams JS, Hewison M: Update in vitamin D. J Clin Endocrinol Metab 2010; 95: 471-478.
10. Osei K: 25-OH vitamin D: is it the universal panacea for metabolic syndrome and type 2 diabetes? J Clin Endocrinol Metab 2010; 95: 4220-4222.
11. Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, Lichtenstein AH, Lau J, Balk EM: Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010; 152: 307-314.
12. Pearce SH, Cheetham TD: Diagnosis and management of vitamin D deficiency. BMJ 2010; 340:b5664.
13. Fraser A, Williams D, Lawlor DA: Associations of serum 25-hydroxyvitamin D, parathyroid hormone and calcium with cardiovascular risk factors: analysis of 3 NHANES cycles (2001-2006). PLoS One 2010; 5:e13882.
14. Zhao G, Ford ES, Li C: Associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with surrogate markers of insulin resistance among US adults without physician-diagnosed diabetes: NHANES, 2003-2006. Diabetes Care 2010; 33: 344-347.
15. Reis JP, von Mühlen D, Miller ER, III: Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol 2008; 159: 41-48.
16. Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C: Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001; 86: 1633-1637.
17. Reis JP, von Mühlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E: Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in communitydwelling older adults. Diabetes Care 2007; 30: 1549-1555.
18. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention, the National Heart, Lung, and Blood Institute, the American Heart Association, the World Heart Federation, the International Atherosclerosis Society and the International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
19. Pinelli NR, Jaber LA, Brown MB, Herman WH: Serum 25-hydroxy vitamin D and insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans. Diabetes Care 2010; 33: 1373-1375.
20. Kayaniyil S, Vieth R, Retnakaran R, Knight JA, Qi Y, Gerstein HC, Perkins BA, Harris SB, Zinman B, Hanley AJ: Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 2010; 33: 1379-1381.
21. Bozkurt NC, Cakal E, Sahin M, Ozkaya EC, Firat H, Delibasi T: The relation of serum 25-hydroxyvitamin-D levels with severity of obstructive sleep apnea and glucose metabolism abnormalities. Endocrine 2012; 41: 518-525.
22. Bonsignore MR, Eckel J: Metabolic aspects of obstructive sleep apnoea syndrome. Eur Respir Rev 2009; 18: 113-124.
23. Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM: Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabetes Care 2005; 28: 2926-2932.
24. Chiu KC, Chu A, Go VL, Saad MF: Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79: 820-825.
25. Zhao G, Ford ES, Li C, Kris-Etherton PM, Etherton TD, Balluz LS: Independent associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with blood pressure among US adults. J Hypertens 2010; 28: 1821-1828.
26. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K: Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007; 167: 1159-1165.
27. Oh J, Weng S, Felton SK, Bhandare S, Riek A, Butler B, Proctor BM, Petty M, Chen Z, Schechtman KB, Bernal-Mizrachi L, Bernal-Mizrachi C: 1,25(OH)2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009; 120: 687-698.
28. Kazlauskaite R, Powell LH, Mandapakala C, Cursio JF, Avery EF, Calvin J: Vitamin D is associated with atheroprotective high-density lipoprotein profile in postmenopausal women. J Clin Lipidol 2010; 4: 113-119.
29. Snijder MB, van Dam RM, Visser M, Deeg DJ, Dekker JM, Bouter LM, Seidell JC, Lips P: Adiposity in relation to vitamin D status and parathyroid hormone levels: a populationbased study in older men and women. J Clin Endocrinol Metab 2005; 90: 4119-4123.
30. Young KA, Engelman CD, Langefeld CD, Hairston KG, Haffner SM, Bryer-Ash M, Norris JM: Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. J Clin Endocrinol Metab 2009; 94: 3306-3313.
31. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF: Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-693.
32. McCarty MF, Thomas CA: PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. Med Hypotheses 2003; 61: 535-542.
33. Snijder MB, Lips P, Seidell JC, Visser M, Deeg DJ, Dekker JM, van Dam RM: Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med 2007; 261: 558-565.
34. Perkovic V, Hewitson TD, Kelynack KJ, Martic M, Tait MG, Becker GJ: Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells. Kidney Blood Press Res 2003; 26: 27-33.
35. Kohler M, Stradling JR: Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol 2010; 7: 677-685.
36. Drager LF, Bortolotto LA, Maki-Nunes C, Trombetta IC, Alves MJ, Fraga RF, Negrao CE, Krieger EM, Lorenzi-Filho G: The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome. Atherosclerosis 2010; 208: 490-495.
37. Gonzalez-molero I, Morcillo S, Valdes S, Perez-Valero V, Botas P, Delgado E, Hernandez D, Olveira G, Rojo G, Gutierrez-Repiso C, Rubio-Martin E, Menendez E, Soriguer F: Vitamin D deficiency in Spain: a populationbased cohort study. Eur J Clin Nutr 2011; 65: 321-328.
38. Saggese G, Federico G, Balestri M, Toniolo A: Calcitriol inhibits the PHA-induced production of IL-2 and IFN-gamma and the proliferation of human peripheral blood leukocytes while enhancing the surface expression of HLA class II molecules. J Endocrinol Invest 1989; 12: 329-335.